89
Views
20
CrossRef citations to date
0
Altmetric
Research Article

Thrombotic Thrombocytopenic Purpura Following Stem Cell Transplantation

, &
Pages 1921-1926 | Published online: 03 Aug 2009

  • [Line 5205]Rock, C.A., Shumak, K.H., Buskard, S.A., Blanchette, VS., Kelton, JG., Nair, R.C and Spasoff, R.A. (1991) "Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thromhocytopenic purpura", N. Engl. J. Med. 325, 393-397.
  • [Line 5239]Holler, E., KoIb, HJ., Hiller, K., Mraz. W., Lehmacher, W., Gleixner, B., Seeber, Ch., Jehn, U., Gerhartz, H.H., Brehm, G. and Wilmanns, W. (1989) "Microangiopathy in patients on cyclosporine prophylaxis who developed acute graft-versus-discase after HLAidentical bone marrow transplantation", Blood 73, 2018-2024.
  • [Line 5277]Fuge, R., Bird, J.M., Fraser, A., Hart, D., Hunt, L., Cornish, J.M., Goulden, N., Dakhill, A., Pamphilon, D.H., Steward, G.G. and Marks, D.I. (2001) "The clinical features, risk factors and outcome of thrombotic thrombocytopenic purpura occurring after bone marrow transplantation", Br. J. Haematol. 113, 58-64.
  • [Line 5315]Roy, V., Rizvi, M.A., Vesely, S.K. and George, J.N. (2001) "Thrombotic thrombocytopenic purpura-like syndromes following hone marrow transplantation: an analysis of associated conditions and clinical outcomes", Bone Marrow Transplant. 27, 641-646.
  • [Line 5346]Hand, J.P., Lawlor, E.R., Yong, C.K.K. and Davis, J.H. (1998) "Successful use of cyclosporine A in the treatment of refractory thrombotic thrombocytopenic purpura", Br. J. Haematol. 100, 597-599.
  • [Line 5377]Van Ojik, H., Biesma, D.W., Fijnheer, R., Hené, R.J. and Lokhurst. H.M. (1997) "Cycloxporin for thrombotic thrombocytopenic purpura after autologous hone marrow- transplantation", Br. J. Huematol. 96, 641-643.
  • [Line 5409]Iacopino, P., Pucci, C., Arcese, W., Busi, A., Falda, M., Locaielli, F., Marenco, P., Minicro, R., Morabilo, F., Rossetti, K. Sica, S., Uderzo, C. and Bacigalupo, A. (1999) "Severe thrombotic microangiopathy: an infrequent complication of bone marrow transplantation", Bone Marrow Transplant. 24, 47-51.
  • [Line 5449]Atkinson, K., Biggs, J.C., Haves, J., Ralston, M., Dodds, A.J., Concannon, A.J. and Naidoo, D. (1983) "Cyclasporin A associated nephrotoxicity in the first 100 days after allogeneic bone marrow transplantation: three distinct syndromes", Br J. Haematol. 54, 59-67.
  • [Line 5483]Rabinowe, S.N., Soiffer, R.J., Tarbell, N.J., Neuberg, D., Freedman. A.S., Seifter, J., Blake, K.W., Gribben, J.G., Anderson, K.C. and Takvorian, T. (1991) "Hemolytic-Uremic syndrome following bone marrow transplantation in adults for hematologie malignancies", Blood 77, 1837-1844.
  • [Line 5520]Tsai, H.-M., Liau, E.C.-Y., "Antibodies to von Willebrand factorcleaving protcasc in acute thrombotic thrombocytopenic purpura", N Engl. J. Med. 339, 1585-1594.
  • [Line 5548]Furlan, M. Robles, R., Galbuscra, M, Kemadzi, G., Kyrie, P.A., Brenner, B., Krause, M., Scharrer, I., Aumann, V. Mittler, U., Sulenthaler, M. and Lammle, B. (1998) "Von Willebrand factorcleaving protcase in thrombotic thrombocytopenic purpura and the hemolytic uremic syndrome", N. Engl. J. Med. 339, 1578-1584.
  • [Line 5587]Van der Plas, R.M., Schiphorst, M.E., Huizinga, E.G., Hene, R.J., Verdonck, L.F., Sixma, J.J. and Fijnheer, R. (1999) "Von Willebrand Factor proteolysis is deficient in classic, but not in bone marrow transplantation-associated, thrombotic thrombocytopenic purpura", Blood 93, 3798-3802.
  • [Line 5621]Cohen, H., Bull, H.A., Seddon, A., Enayat, M.S., Hill, F.G., Woolf, N. and Machin, S.J. (1989) "Vascular enduthelial cell function and ultrastructure in thrombotic microangiopathy following allogeneic bone marrow transplantalion", Eur. J. Haematol. 43, 207-214.
  • [Line 5655]Collins, P.W., Gutteridge, C.N., O'Driscoll, A., Blair, S., Jones, L., Aitchison, R., Kelsey, S.M., Chopra, R., Goldstone, A and Newland, A.C. (1992) "Von Willebrand factor as a marker of endothelial cell activation following BMT", Bane marrow Transplant. 10, 499-506.
  • [Line 5692]Zeigler, Z., Kelton, J., Moore, J., Shadduck, Ill DA. R., Nath, R. and Agha, M. (1999) "Calpain activity in bone marrow transplantassociated thrombotic thrombocytopenic purpura", Bane Marrow Transplant. 24, 641-645.
  • [Line 5725]Brown, Z., Neild, G.H., Willoughby, JJ., Somnia, S.V. and Cameron, SJ. (1986) "Increased factor VIII as an index of vascular injury in cyclosporine nephratoxicity", Transplantation 42, 150.
  • [Line 5755]Moore, L.C., Mason, J., Feld, L., Van Liew, J.B. and Kaskel, F.J. (1992) "Effect of cyclosporine on endothelial albumin leakage in rats", J. Am. Soc. Nephral. 3, 51-57.
  • [Line 5787]Peters, A.M. Vassilarou, D.S., Hows, J.M. and Ballardie, F.W. (1991) "Bone marrow transplantation: effects of conditioning and cyclosporin prophylaxis on tricovascular permeability to a small solute (Techetium-99 m diethylene triaminc penta-acetic acid)", Eur. J. Nucl. Med 18, 199-202.
  • [Line 5818]Grace, A.A., Barbados, M.A., Mikhatlidis, O.P., Jeremy, J.Y, Moorhead, J.F., Sweny, P. and Dandona, P. (1987) "Cyclosporin A enhances platelet aggregation", Kidney Int. 32, 889-895.
  • [Line 5852]Schriber, J.R. and Herzig, G.P. (1997) "Transplantation-associated thrombotic thrombocytopenic purpura and hemolytic uremic syndrome", Semin, Hematol. 34, 126-130.
  • [Line 5881]Anthony, M.T., Zeigler, Z.R. Lister, J., Raymond, J.M., Shadduck, R.K., Kramer, R.E., Gryn, J.F., Rintels, P.B., Besu, E.C., George, J.N., Silver, B., Joyce, R. and Bodensteiner. D. (1998) "Plasminogen activator inhibitor (PAI-1) antigen levels in primary TTP and secondary TTP post-bone marrow transplantation", Am. J. Hematol., 9-14.
  • [Line 5921]Kelton, J.G., Moore, J.C., Warkentin, T.E. and Hayward, C.P.M. (1996) "Isolation and characterisation of cysteine protcinase in thrombotic thromhocytopenic purpura", Br. J. Huenmtol. 93, 421-426.
  • [Line 5952]Seeber, C., Hiller, H., Holler, E. and KoIh, H.J. (1992) "Increased levels of tissue plasminogen activator (t-PA) and tissue plasminogen activator inhibitor (PAI) correlate with tumour necrosis factor alpha (TTF alpha)-release in patients suffering from microangtopathy following allogeneic hone marrow transplantation (BMT)", Thmmb. Res. 66, 373-3S3.
  • [Line 5983]Middleton, P.C., Taylor, P.R.A., Jackson, G. Proctur, S.J and Dickinson, A.M. (1998) "Cytokine polymorphisms associating with severe acute graft-versus-host disease in HLA-idcntical sibling transplants", Blood 92, 3943-3948.
  • [Line 6015]Cavet, J., Dickinson, A.M., Norden, J., Taylor, P.R.A., Jackson, G.H and Middleton, P.O. (2001) "Interferon-g and inlerlcukin-6 gene polymorphisms, associate with graft-versus-host disease in HLA-matched sibling bone marrow transplantation", Blood 98, 1594-1600.
  • [Line 6048]Sarode, R., McFarland, J.G., Homenherg, N., Casper, J.T., Cohen, E.P., Drobyski, W.R., Ash, R.C., Horowitz, M.M., Camitta, B. and Lawton, C. (1995) "Therapeutic plasma exchange does not appear to be effective in the management of thrombotic thrombocytopenic purpura/hemolytic uremic syndrome following bone marrow transplantation", Bone Marrow Transplant, 16, 271-275.
  • [Line 6085]Percira, A., Mazzara, R., Monteagiido, J., Sunz, C., Puig, L., Martinez, A., Ordinas, A. and Custillo, R. (1995) "Thrombotic thrombocytopenic purpura/hemoljtic uremic syndrome: a multivariate analysis of factors predicting the response to plasma exchange", Ann. Hematol. 70, 319-323.
  • [Line 6120]Rock, G., Kellon, S.C., Shumak, K.H., Buskard, N.A., Sutton, D.M. and Benny, W.B. (1998) "Laboratory abnonnalities in thrombotic thrombocytopenic purpura Canadian Apheresis Group", Br, J. Haematol 103, 1031-1036.
  • [Line 6153]Wada, H., Mori, Y., Shimura, M., Hiyoyama, K., Ioka, M., Nakasaki, T., Nishikawa, M., Nakano, M. Kumeda, K., Kaneko, T., Nakamura, S. and Shiku, H. (1998) "Poor outcome in disseminated intiavascular coagulation or thrombotic throinbocytopenic purpura patients with severe vascular endothetial cell injuries", Am. J. Hematol. 58, 189-194.
  • [Line 6192]Milone, J., Napal, J., Bordone, J., Etchegoyen, O. and Morales, V. (1998) "Complete response in severe thrombotic microangiopathy post bone morrow transplantation (BMT-TM) after multiple plasmaphereses", Bone Marrow Transplant. 22, 1019-1021.
  • [Line 6224]Caddis, T.G., Guthrie, T.H., Drew, M.J., Sahud, M., Howe, R.B. and Miltelman, A. (1997) 'Treatment of plasma refractory thrombotic thrombocytopcnic purpura with proleiu A immunoadsorption", Am. J. Hematol, 55, 55-58.
  • [Line 6257]Zeigler, Z.R., Shadduck, R.K., Nath, R. and Andrews, D.F. (1996) "Pilot study of combined cryosupcrnatanl and protein A immunoadsorption exchange in the treatment of grade 3-4 bone marrow transplant-associated thrombotic microangiopathy", Bone Marrow Transplant. 17, 81-86.
  • [Line 6288]George, J.N. (2000) "How I treat patients with thrombotic thrombocytopenic purpura-heuiolytic uremic syndrome", Blood 96, 1223-1229.
  • [Line 6316]Chappell, M.E., Keeling, D.M., Prentice, H.G. and Sweny, P. (1988) "Hacmolytic uraemic syndrome after bone marrow transplantation: an adverse effect of total body irradiation?", Bane Marrow Transplant. 3, 339-347.
  • [Line 6347]Corti, P., Uderzo, C., Tagliabuc, A., Delia Volpe, A., Annaioro, C., Tageiaferri, E. and Balduzzi, A. (2002) "Detihrotide as a promising treatment for thrombotic thrombocytopenic purpura in patients undergoing bone marrow transplantation", Bone Marrow Transplant. 29, 542-543.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.